This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Jun 14;361(9374):2000-1.

doi: 10.1016/S0140-6736(03)13672-0.

Major benefits from cholesterol-lowering in patients with diabetes

Lars H Lindholm¹

Affiliations

PMID: 12814705
DOI: 10.1016/S0140-6736(03)13672-0

Comment

Major benefits from cholesterol-lowering in patients with diabetes

Lars H Lindholm. Lancet. 2003.

. 2003 Jun 14;361(9374):2000-1.

doi: 10.1016/S0140-6736(03)13672-0.

Author

Lars H Lindholm¹

Affiliation

¹ Department of Public Health and Clinical Medicine, Umeå University Hospital, SE 901 85, Umeå, Sweden. larsh.lindholm@fammed.umu.se

PMID: 12814705
DOI: 10.1016/S0140-6736(03)13672-0

No abstract available

PubMed Disclaimer

Comment in

Comments on the MRC/BHF Heart Protection Study.
Sirtori CR. Sirtori CR. Lancet. 2003 Aug 30;362(9385):744; author reply 744-5. doi: 10.1016/S0140-6736(03)14213-4. Lancet. 2003. PMID: 12957102 No abstract available.

Comment on

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.
Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group. Collins R, et al. Lancet. 2003 Jun 14;361(9374):2005-16. doi: 10.1016/s0140-6736(03)13636-7. Lancet. 2003. PMID: 12814710 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information